Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK/PD of Dabigatran Etexilate in Moderate Hepatic Impairment
NCT02170571Phase 1Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Jul 2005
- Primary completion
- Dec 2005
- Modality
- Small Molecules
01
Overview
Phase 1, open-label trial of dabigatran in thromboembolism (2 arms), sponsored by Boehringer Ingelheim. Primary endpoints: Area under the concentration-time curve from 0 to infinity, Maximum plasma concentration and 2 more. Started Jul 2005; status: completed.
02
Drugs
dabigatran
03
Conditions
thromboembolism
Beyond the preview
Go deeper on NCT02170571.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02170571.